A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)

PHASE2CompletedINTERVENTIONAL

Enrollment

128

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

bevacizumab

Intravenous repeating dose

DRUG

carboplatin

Intravenous repeating dose

DRUG

paclitaxel

Intravenous repeating dose

DRUG

placebo

Intravenous repeating dose

DRUG

PRO95780

Intravenous repeating dose